These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27934923)

  • 21. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
    Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ
    Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of luteolin‑4'‑O‑β‑D‑glucopyranoside on P2Y12 and thromboxane A2 receptor‑mediated amplification of platelet activation in vitro.
    Xu H; Lu H; Zhu X; Wang W; Zhang Z; Fu H; Ma S; Luo Y; Fu J
    Int J Mol Med; 2018 Jul; 42(1):615-624. PubMed ID: 29693158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.
    Yang Y; Wang X; Zhang L; An H; Zao Z
    Am J Chin Med; 2011; 39(1):145-59. PubMed ID: 21213405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
    Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
    Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.
    Klages B; Brandt U; Simon MI; Schultz G; Offermanns S
    J Cell Biol; 1999 Feb; 144(4):745-54. PubMed ID: 10037795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
    Riondino S; Gazzaniga PP; Pulcinelli FM
    Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homologous desensitization of signalling by the alpha (alpha) isoform of the human thromboxane A2 receptor: a specific role for nitric oxide signalling.
    Kelley-Hickie LP; O'Keeffe MB; Reid HM; Kinsella BT
    Biochim Biophys Acta; 2007 Jun; 1773(6):970-89. PubMed ID: 17466390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor; pharmacological and kinetic studies in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003 Sep; 14(6):359-74. PubMed ID: 14602550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets.
    Dorsam RT; Kim S; Jin J; Kunapuli SP
    J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase.
    Iida Y; Doi T; Tokuda H; Matsushima-Nishiwaki R; Tsujimoto M; Kuroyanagi G; Yamamoto N; Enomoto Y; Tanabe K; Otsuka T; Iwama T; Ogura S; Kozawa O; Iida H
    Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():73-81. PubMed ID: 25500336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A platelet secretion pathway mediated by cGMP-dependent protein kinase.
    Li Z; Zhang G; Marjanovic JA; Ruan C; Du X
    J Biol Chem; 2004 Oct; 279(41):42469-75. PubMed ID: 15280395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N; Mais DE; Halushka PV
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
    Kinsella BT; O'Mahony DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1997 May; 281(2):957-64. PubMed ID: 9152406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
    Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J
    Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin-permeabilized platelets.
    Knezevic I; Dieter JP; Le Breton GC
    J Pharmacol Exp Ther; 1992 Mar; 260(3):947-55. PubMed ID: 1545407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.